High peripheral blood progenitor cell counts enable autologous backup before stem cell transplantation for malignant infantile osteopetrosis

Biology of Blood and Marrow Transplantation

Volumn 11, Issue 2, 2005, Pages 115-121

  Steward, Colin G ^a   Blair, A ^b   Moppett, J ^a   Clarke, E ^b   Virgo, P ^c   Lankester, A ^b   Burger, S R ^d   Sauer, M G ^d   Flanagan, A M ^e   Pamphilon, D H ^b   Orchard, P J ^d  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Leukoerythroblastic; Osteoclasts; Osteopetrosis; Peripheral blood stem cells

Indexed keywords

BUSULFAN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALBERS SCHOENBERG DISEASE; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD CELL COUNT; BLOOD VOLUME; BONE MARROW CELL; BURST FORMING UNIT E; CHILD; CLINICAL ARTICLE; COLONY FORMING UNIT GM; COMPARATIVE STUDY; CONTROLLED STUDY; EXCHANGE BLOOD TRANSFUSION; GRAFT FAILURE; HUMAN; PERIPHERAL BLOOD STEM CELL; REIMPLANTATION;

EID: 19944431452     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2004.11.001     Document Type: Article

References (25)

1. A. Fasth O. Porras Human malignant osteopetrosis: Pathophysiology, management and the role of bone marrow transplantation Pediatr Transplant 3 suppl 1 1999 102-107
2. L.L. Key Jr W.L. Ries R.M. Rodriguiz et al. Recombinant human interferon gamma therapy for osteopetrosis J Pediatr 121 1992 119-124
3. E.J. Gerritsen J.M. Vossen I.H. van Loo et al. Autosomal recessive osteopetrosis: Variability of findings at diagnosis and during the natural course Pediatrics 93 1994 247-253
4. L.L. Key Jr R.M. Rodriguiz S.M. Willi et al. Long-term treatment of osteopetrosis with recombinant human interferon gamma N Engl J Med 332 1995 1594-1599
5. G.J. Driessen E.J. Gerritsen A. Fischer et al. Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: An EBMT report Bone Marrow Transplant 32 2003 657-663
6. E.J. Gerritsen J.M. Vossen A. Fasth et al. Bone marrow transplantation for autosomal recessive osteopetrosis: A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group J Pediatr 125 1994 896-902
7. G. Cournot M. Petrovic C.L. Trubert et al. Cultured circulating mononuclear cells from osteopetrotic infants express the osteoclast-associated vitronectin receptor and form multinucleated cells in response to 1,25-dihydroxyvitamin D3 J Bone Miner Res 8 1993 61-70
8. J.R. Marcus E. Fibach M. Aker Circulating myeloid and erythroid progenitor cells in malignant osteopetrosis Acta Haematol 67 1982 185-189
9. A.M. Flanagan H.M. Massey C. Wilson et al. Macrophage colony-stimulating factor and receptor activator NF-kappaB ligand fail to rescue osteoclast-poor human malignant infantile osteopetrosis in vitro Bone 30 2002 85-90
10. A.M. Flanagan U. Sarma C.G. Steward et al. Study of the nonresorptive phenotype of osteoclast-like cells from patients with malignant osteopetrosis: A new approach to investigating pathogenesis J Bone Miner Res 15 2000 352-360
11. F. Shapiro Osteopetrosis. Current clinical considerations Clin Orthop 34 1993 34-44
12. M. Srinivasan M. Abinun A.J. Cant et al. Malignant infantile osteopetrosis presenting with neonatal hypocalcaemia Arch Dis Child Fetal Neonatal Ed 83 2000 F21-F23
13. C.G. Steward Neurological aspects of osteopetrosis Neuropathol Appl Neurobiol 29 2003 87-97
14. I.K. McNiece K.E. Langley K.M. Zsebo Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages Exp Hematol 19 1991 226-231
15. E. Clarke M.N. Potter A. Oakhill et al. A laboratory comparison of T cell depletion by CD34+ cell immunoaffinity selection and in vitro Campath-1M treatment: Clinical implications for bone marrow transplantation and donor leukocyte therapy Bone Marrow Transplant 20 1997 599-605
16. C.A. Sieff J.M. Chessells R.J. Levinsky et al. Allogeneic bone-marrow transplantation in infantile malignant osteopetrosis Lancet 1 1983 437-441
17. G. Chikkappa A.L. Carsten A.D. Chanana et al. Increased granulocytic, erythrocytic, and megakaryocytic progenitors in myelofibrosis with myeloid metaplasia Am J Hematol 4 1978 121-131
18. B. Andreasson B. Swolin J. Kutti Patients with idiopathic myelofibrosis show increased CD34+ cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia Eur J Haematol 68 2002 189-193
19. J.A. Hibbin O.S. Njoku E. Matutes et al. Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders Br J Haematol 57 1984 495-503
20. C.G. Steward I. Pellier A. Mahajan et al. Severe pulmonary hypertension: a frequent complication of stem cell transplantation for malignant infantile osteopetrosis Br J Haematol 124 2004 63-71
21. K.A. Kasow C. Bonfim J. Asch et al. Malignant infantile osteopetrosis and primary pulmonary hypertension: A new combination? Pediatr Blood Cancer 42 2004 190-194
22. C. Sobacchi A. Frattini P. Orchard et al. The mutational spectrum of human malignant autosomal recessive osteopetrosis Hum Mol Genet 10 2001 1767-1773
23. A. Frattini A. Pangrazio L. Susani et al. Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis J Bone Miner Res 18 2003 1740-1747
24. C. Sen R. Madazli F. Aksoy et al. Antenatal diagnosis of lethal osteopetrosis Ultrasound Obstet Gynecol 5 1995 278-280
25. S.N. Popoff G.B. Schneider Animal models of osteopetrosis: The impact of recent molecular developments on novel strategies for therapeutic intervention Mol Med Today 2 1996 349-358